{"version":"1.0","type":"link","title":"Immune checkpoint inhibitors combined with anti-angiogenic therapy as second- or further-line treatment for small cell lung cancer: Efficacy, safety, and prognostic biomarkers.","author_name":"Chen T 외","author_url":"https://prs-insight.online/author/Chen%20T","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98016","thumbnail_width":1200,"thumbnail_height":630}